Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disparities in germline testing among racial minorities with prostate cancer
Nicole Weise, Justin Shaya, Juan Javier‐Desloges, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 25, Iss. 3, pp. 403-410
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline
Nadine Tung, Charité Ricker, Hans Messersmith, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 21, pp. 2599-2615
Closed Access | Times Cited: 24
Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis
Vivek Subbiah, Razelle Kurzrock
Journal of Clinical Oncology (2023) Vol. 41, Iss. 17, pp. 3100-3103
Open Access | Times Cited: 36
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer
Heather H. Cheng, Alexandra Sokolova, Roman Gulati, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 13
“Hope at a better chance”: perspectives on genetic counseling and testing among black individuals with prostate cancer
Breanne Prindeville, Brittany M. Szymaniak, Samantha Greenberg, et al.
Journal of Community Genetics (2025)
Open Access
Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment
Fionnuala Crowley, Sonal Gandhi, Michelle Rudshteyn, et al.
The Oncologist (2023) Vol. 28, Iss. 6, pp. 486-493
Open Access | Times Cited: 11
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)
Andrew J. Armstrong, Amy K. Taylor, Michael Haffner, et al.
Prostate Cancer and Prostatic Diseases (2024)
Open Access | Times Cited: 4
Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer
Daniel H. Kwon, Kelly Gordon, Barry Tong, et al.
JCO Oncology Practice (2023) Vol. 19, Iss. 5, pp. e773-e783
Closed Access | Times Cited: 9
Disparities in prostate cancer
Arthur L. Burnett, Yaw A. Nyame, Edith P. Mitchell
Journal of the National Medical Association (2023) Vol. 115, Iss. 2, pp. S38-S45
Open Access | Times Cited: 8
The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality
Giovanni Farinea, Veronica Crespi, Angela Listì, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 9, pp. 1146-1164
Open Access | Times Cited: 8
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer
Jacob E. Berchuck, Daniel Boiarsky, Rebecca Silver, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 13
Communicating risk and the landscape of cancer prevention — an exploratory study that examines perceptions of cancer-related genetic counseling and testing among African Americans and Latinos in the Midwest
Crystal Y. Lumpkins, Rafaela Nelson, Zawadi Twizele, et al.
Journal of Community Genetics (2023) Vol. 14, Iss. 2, pp. 121-133
Open Access | Times Cited: 7
Integrating Broad Panel Somatic and Germline Testing in Prostate Cancer Care
Ralph J. Henderson, Robert A. Bailey, Ibrahim Khilfeh, et al.
JU Open Plus (2024) Vol. 2, Iss. 12
Open Access | Times Cited: 2
Usefulness of podcasts to provide public education on prostate cancer genetics
Stacy Loeb, Tatiana Sanchez Nolasco, Katherine Siu, et al.
Prostate Cancer and Prostatic Diseases (2023) Vol. 26, Iss. 4, pp. 772-777
Closed Access | Times Cited: 6
Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care
Christine M. Gunn, Emma X. Li, Gretchen A. Gignac, et al.
Cancer Control (2023) Vol. 30
Open Access | Times Cited: 6
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?
Olivier Cussenot, Géraldine Cancel‐Tassin, Srinivasa R. Rao, et al.
BJU International (2023) Vol. 132, Iss. 5, pp. 472-484
Closed Access | Times Cited: 5
Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada
Shamini Selvarajah, Kasmintan A. Schrader, Michael Kolinsky, et al.
Canadian Urological Association Journal (2022) Vol. 16, Iss. 10
Open Access | Times Cited: 8
Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes
Paul Riviere, Sandhya Kalavacherla, Matthew P. Banegas, et al.
Cancer (2022) Vol. 129, Iss. 1, pp. 82-88
Closed Access | Times Cited: 8
The costs and inequities of precision medicine for patients with prostate cancer: A call to action
Meera Ragavan, Hala T. Borno
Urologic Oncology Seminars and Original Investigations (2023) Vol. 41, Iss. 9, pp. 369-375
Closed Access | Times Cited: 4
Germline Mutations and Ancestry in Prostate Cancer
Eudoxie Bataba, Kevin Babcock, Kathryn A. Isensee, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 2, pp. 175-180
Open Access | Times Cited: 1
Understanding and Addressing Prostate Cancer Disparities in Diagnosis, Treatment, and Outcomes Among Black Men
Anastasia Murphy, Cherell Cottrell‐Daniels, Shivanshu Awasthi, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 1
New Drug Development and Clinical Trial Design by Applying Genomic Information Management
Young Kyung Ko, Jeong‐An Gim
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1539-1539
Open Access | Times Cited: 5
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans
Linda D. Bosserman, Isa Mambetsariev, Colton Ladbury, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6738-6738
Open Access | Times Cited: 5
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer
Katharina Rebhan, P. Stelzer, Benjamin Pradère, et al.
World Journal of Urology (2023) Vol. 41, Iss. 8, pp. 2091-2097
Open Access | Times Cited: 2
Utilizing Public Health Frameworks and Partnerships to Ensure Equity in DNA-Based Population Screening
Elyse Azriel, Candace Henley, Joan Ehrhardt, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race
Mehmet Asım Bilen, Ibrahim Khilfeh, Carmine Rossi, et al.
ClinicoEconomics and Outcomes Research (2024) Vol. Volume 16, pp. 657-674
Open Access
Page 1 - Next Page

Scroll to top